Cargando…

Intraoperative Mitomycin C Bladder Instillation During Radical Nephroureterectomy Is Feasible and Safe

BACKGROUND: Bladder recurrence after radical treatment of upper urinary tract urothelial cancer (UTUC) is frequent, and patients are required to undergo surveillance cystoscopies following surgery. The use of intravesical adjuvant chemotherapy is an accepted method to prevent bladder recurrence, but...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nadler, Naomi, Oedorf, Kimie, Jensen, Jørgen Bjerggaard, Azawi, Nessn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Urothelial Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655381/ https://www.ncbi.nlm.nih.gov/pubmed/34934966 http://dx.doi.org/10.1016/j.euros.2021.09.013

Ejemplares similares

Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group
por: Dobé, Tom-Régis, et al.
Publicado: (2020)

Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at Surgery
por: Soria, Francesco, et al.
Publicado: (2022)

Single-nucleus and Spatially Resolved Intratumor Subtype Heterogeneity in Bladder Cancer
por: Lindskrog, Sia V., et al.
Publicado: (2023)

Survival and Long-term Effects of Kidney-sparing Surgery Versus Radical Nephroureterectomy on Kidney Function in Patients with Upper Urinary Tract Urothelial Carcinoma
por: Hendriks, Nora, et al.
Publicado: (2022)

Site-specific Risk Stratification Models for Postoperative Recurrence and Survival Prediction in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: Better Stratification for Adjuvant Therapy
por: Miyake, Makito, et al.
Publicado: (2022)

Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study
por: Grossmann, Nico C., et al.
Publicado: (2022)

The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy
por: D'Andrea, David, et al.
Publicado: (2022)

Prediction of Metastatic Patterns in Bladder Cancer: Spatiotemporal Progression and Development of a Novel, Web-based Platform for Clinical Utility
por: Mason, Jeremy, et al.
Publicado: (2021)

STAG2 Protein Expression in Non–muscle-invasive Bladder Cancer: Associations with Sex, Genomic and Transcriptomic Changes, and Clinical Outcomes
por: Gordon, Naheema S., et al.
Publicado: (2022)

Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy
por: Marcq, Gautier, et al.
Publicado: (2022)

Long-term Follow-up After En Bloc Transurethral Resection of Non–muscle-invasive Bladder Cancer: Results from a Single-center Experience
por: Paciotti, Marco, et al.
Publicado: (2021)

Real-world Treatment Patterns and Overall Survival in Locally Advanced and Metastatic Urothelial Tract Cancer Patients Treated with Chemotherapy in Denmark in the Preimmunotherapy Era: A Nationwide, Population-based Study
por: Omland, Lise H., et al.
Publicado: (2020)

Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?
por: Rodler, Severin, et al.
Publicado: (2020)

The Association Between Renal Function Decline and the Incidence of Urothelial Carcinoma: A 16-year Retrospective Cohort Study in Taiwan
por: Chuang, Yung-Hsin, et al.
Publicado: (2021)

Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis
por: Khalid, Sidra, et al.
Publicado: (2020)

International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members
por: Beijert, Irene J., et al.
Publicado: (2023)

Is a Single Nephrographic Phase Computed Tomography Sufficient for Detecting Urothelial Carcinoma in Patients with Visible Haematuria? A Prospective Paired Noninferiority Comparison
por: Galtung, Kristina F., et al.
Publicado: (2023)

Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort
por: Zschäbitz, Stefanie, et al.
Publicado: (2023)

Location of Retroperitoneal Lymph Node Metastases in Upper Tract Urothelial Carcinoma: Results from a Prospective Lymph Node Mapping Study
por: Bobjer, Johannes, et al.
Publicado: (2023)

Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies
por: Mertens, Laura S., et al.
Publicado: (2023)

Oncologic outcomes of radical nephroureterectomy (RNU)
por: Kenigsberg, Alexander P., et al.
Publicado: (2020)

Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy
por: Moriarty, Michael A., et al.
Publicado: (2015)

Controversies in management of the bladder cuff at nephroureterectomy
por: Braun, Avery E., et al.
Publicado: (2020)

Perioperative complications and adverse sequelae of radical nephroureterectomy
por: Levy, Alison, et al.
Publicado: (2020)

Effectiveness of an Immediate Mitomycin C Instillation in Patients with Superficial Bladder Cancer Receiving Periodic Mitomycin C Instillation
por: Jung, Seok Jin, et al.
Publicado: (2011)

SPTAN1, APC, and FGFR3 Mutation Status and APOBEC Mutation Signatures are Predictive of Mitomycin C Response in Non-muscle-invasive Bladder Cancer
por: Lindgren, Maria Skydt, et al.
Publicado: (2021)

Trial-based Cost-effectiveness Analysis of an Immediate Postoperative Mitomycin C Instillation in Patients with Non–muscle-invasive Bladder Cancer
por: Hentschel, Anouk E., et al.
Publicado: (2022)

Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes
por: Catto, James W.F., et al.
Publicado: (2021)

Prognostic Value of Tumor Size in Patients with Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis
por: Ma, Runzhuo, et al.
Publicado: (2022)

Incidence and preoperative predictors for major complications following radical nephroureterectomy
por: Kocher, Neil J., et al.
Publicado: (2020)

Surveillance of Low-Grade Non-Muscle Invasive Bladder Tumors Using Uromonitor: SOLUSION Trial
por: Azawi, Nessn, et al.
Publicado: (2023)

The role of lymphadenectomy at the time of radical nephroureterectomy for upper tract urothelial carcinoma
por: Goltzman, Michael E., et al.
Publicado: (2020)

Prophylactic effects of Bacille Calmette-Guérin intravesical instillation therapy: Time period-related comparison between Japan and Western countries
por: Okamura, Takehiko, et al.
Publicado: (2013)

Intravesical Instillation of Mitomycin C: A Cause of Delayed Bladder Perforation?
por: Penna, Marta, et al.
Publicado: (2012)

Immediate gemcitabine bladder instillation following bladder closure during robotic-assisted radical nephroureterectomy: a multi-institutional report of feasibility and initial outcomes
por: Said, Mohammed A., et al.
Publicado: (2023)

Evaluation of Intraoperative Versus Postoperative Adjuvant Mitomycin C with Nephroureterectomy for Urothelial Carcinoma of the Upper Urinary Tract
por: Noennig, Blake, et al.
Publicado: (2018)

Comparison of the Comprehensive Complication Index and Clavien-Dindo systems in predicting perioperative outcomes following radical nephroureterectomy
por: Geiger, Scott, et al.
Publicado: (2020)

Optimal Delivery of Follow-Up Care After Radical Cystectomy for Bladder Cancer
por: Jensen, Bente Thoft, et al.
Publicado: (2020)

Perioperative immunotherapy in muscle-invasive bladder cancer
por: Lee, Hyung Ho, et al.
Publicado: (2020)

Singe intraoperative instillation of chemotherapy during radical cystectomy for bladder cancer: Oncological outcome and survival predictors
por: Yang, Jingtian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c5gug1h743iqjegb5jbp4mlmvu